Min Hye Jang - Concepedia

Author

Min Hye Jang

Seoul National University Bundang Hospital ORCID

Also Known As

M H Jang, Min Hye Jang, Min Jang

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Seoul National University Bundang Hospital Seoul National University Yeungnam University Medical Center Asan Medical Center New Generation University College

About

Min Hye Jang is an author at Seoul National University Bundang Hospital specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1K
2	Cell Biology	3	3	285
3	Health Sciences	1	1	16
4	Public Health	1	1	54
5	Biostatistics	1	1	54

Min Hye Jang

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer An Na Seo, Heon‐Jin Lee, Eunice Kim, British Journal of Cancer	2013	325
High EGFR gene copy number predicts poor outcome in triple-negative breast cancer Heae Surng Park, Min Hye Jang, Eun Joo Kim, Modern Pathology Breast OncologyPoor OutcomeMedicinePathologyCancer Genomics	2014	283
Expression of epithelial-mesenchymal transition–related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome Min Hye Jang, Hyun Jeong Kim, Eun Joo Kim, Human Pathology Breast OncologyOncologyEpithelial-mesenchymal Transition–related MarkersMedicinePoor Clinical Outcome	2015	165
Prognostic and predictive values of EGFR overexpression and EGFR copy number alteration in HER2-positive breast cancer Heon‐Jeong Lee, An Na Seo, Eunice Kim, British Journal of Cancer	2014	142
<i>HER2</i> Heterogeneity Affects Trastuzumab Responses and Survival in Patients With HER2-Positive Metastatic Breast Cancer Hee Jin Lee, An Na Seo, Eun Joo Kim, American Journal of Clinical Pathology	2014	137
Prognostic Value of Tumor-Associated Macrophages According to Histologic Locations and Hormone Receptor Status in Breast Cancer Jae Moon Gwak, Min Hye Jang, Dong Il Kim, PLoS ONE Hormone Receptor StatusTumor-associated MacrophagesBreast OncologyImmunologyPathology	2015	129
Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer Yoomi Choi, Hee Jin Lee, Min Hye Jang, Human Pathology Tumor BiologyEpithelial-mesenchymal TransitionBreast OncologyOncologyMedicine	2013	89
Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance Jae Moon Gwak, Milim Kim, Hyun Jeong Kim, Oncotarget	2017	84
FGFR1 is amplified during the progression of in situto invasive breast carcinoma Min Hye Jang, Eun Joo Kim, Yoomi Choi, Breast Cancer Research	2012	76
Prognostic Significance of <i>TERT</i> Promoter Mutations in Papillary Thyroid Carcinomas in a <i> BRAF <sup>V600E</sup> </i> Mutation–Prevalent Population Seung Eun Lee, Tae Sook Hwang, Yoon‐La Choi, Thyroid	2016	75

Page 1